Janie Duvenhage^1,2,3、Jan Rijn Zeevaart^2,3,4、Cecile Swanepoel³、Liani Smith³、Lyn-Marie Birkholtz¹、Thomas Ebenhan^2,3,5 (1.University of Pretoria, Department of Biochemistry, Genetics and Microbiology、2.South African Nuclear Energy Corporation、3.Nuclear Medicine Research Infrastructure 、4.North-West University/ Pre-clinical drug development platform、5.University of Pretoria, Department of Nuclear Medicine)

Yuka Muranaka¹、Asuka Mizutani¹、Masato Kobayashi¹、Kodai Nishi²、Kana Yamazaki³、Ryuichi Nishii³、Naoto Shikano⁴、Shigefumi Okamoto^1,5、Keiichi Kawai^1,6 (1.Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University、2.Department of Radioisotope Medicine, Atomic Bomb Disease Institute, Nagasaki University、3.Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, Quantum Life and Medical Science Directorate, National Institutes for Quantum and Radiological Science and Technology、4.Department of Radiological Sciences, Ibaraki Prefectural University of Health Sciences、5.Advanced Health Care Science Research Unit, Innovative Integrated Bio-Research Core Institute for Frontier Science Initiative, Kanazawa University、6.Biomedical Imaging Research Center, University of Fukui)

Genki Yoshino、Kohei Nakajima、Hideo Takakura、Mikako Ogawa (Graduate School of Pharmaceutical Sciences, Hokkaido University)

Asuka Mizutani¹、Masato Kobayashi¹、Yuka Muranaka¹、Kodai Nishi²、Chie Suzuki³、Ryuichi Nishii ⁴、Naoto Shikano⁵、Yasuhiro Magata³、Keiichi Kawai¹ (1.Kanazawa University、2.Nagasaki University、3.Hamamatsu University School of Medicine、4.National Institutes for Quantum and Radiological Science and Technology、5.Ibaraki Prefectural University of Health Sciences、6.University of Fukui)

Shuang Wu、Yuanxue Gao、Jiayue Pan、Jingjing Shi、Hong Zhang、Mei Tian (The Second Hospital, Zhejiang University School Of Medicine, Zhejiang, Hangzhou, China)

Hiroshi Wakabayashi¹、Junichi Taki¹、Hiroshi Mori¹、Tomo Hiromasa¹、Norihito Akatani¹、Anri Inaki¹、Takashi Kozaka²、Yoji Kitamura²、Kazuma Ogawa³、Seigo Kinuya¹ (1.Dept. of Nuclear Medicine, Kanazawa University Hospital、2.Division of Probe Chemistry for Disease Analysis, Research Center for Experimental Modeling of Human Disease, Kanazawa University、3.Institute for Frontier Science Initiative, Kanazawa University)

Yong-il Kim、Seung Hak Lee、Jin Hwa Chung、Seog-Young Kim、Nare Ko、Sang Ju Lee、Seung Jun Oh、Jin-Sook Ryu、Won Kim、Dabin Ko (Asan Medical Center)

Yan Zhong、Youyou Zhou、Xiaoqing Xin、Yu Liu、Peili Cen、Mei Tian、Hong Zhang (The Second Affiliated Hospital Of Zhejiang University School Of Medicine, Hangzhou, China)

Rui Zhou、Shufang Qian、Xiaoyun Luo、Shuilin Zhao、Zhoujiao Xu、Mei Tian、Hong Zhang (The Second Affiliated Hospital Of Zhejiang University)

Xiao He¹、Jia-dong Chen³、Pei-li Cen^1,7、Li Shen⁴、Meng-jiao Tu^1,7、Fei Huang⁴、Mei Tian^1,5,6、Hong Zhang^1,7,8,9 (1.Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine、2.Department of Radiology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine、3.Center for Neuroscience and Department of Neurosurgery of the Second Affiliated Hospital, NHC and CAMS Key Laboratory of Medical Neurobiology, MOE Frontier Science Center for Brain Research and Brain-Machine Integration, School of Brain Science and Brain Medicine, Zhejiang University School of Medicine、4.The MOE Key Laboratory of Biosystems Homeostasis & Protection and Zhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University、5.PET Center, Huashan Hospital, Fudan University、6.Human Phenome Institute, Fudan University、7.Key Laboratory of Medical Molecular Imaging of Zhejiang Province、8.The College of Biomedical Engineering and Instrument Science of Zhejiang University、9.Key Laboratory for Biomedical Engineering of Ministry of Education, Zhejiang University)